Naproxen / Esomeprazole Rowex Ltd (Esomeprazole, Naproxen)

Naproxen and Esomeprazole, the active ingredients in Naproxen / Esomeprazole Rowex Ltd, are a non‑steroidal anti‑inflammatory drug (NSAID) and a proton pump inhibitor (PPI) presented as an oral tablet for oral use. The combination is intended to relieve pain and inflammation while protecting the stomach lining from NSAID‑related irritation. GNH USA supplies Naproxen / Esomeprazole Rowex Ltd as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen / Esomeprazole acts on inflammatory and gastric pathways to manage pain and protect the gastrointestinal tract. - Pain relief: reduces musculoskeletal pain associated with acute and chronic conditions. - Osteoarthritis: alleviates joint pain and improves functional mobility. - Rheumatoid arthritis: diminishes inflammatory joint symptoms and swelling. - Prevention of NSAID‑induced gastric ulcers: provides gastro‑protective effect while NSAID therapy is required.

The combination may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dyspepsia: discomfort or burning in the upper abdomen. - Nausea: feeling of sickness often accompanied by an urge to vomit. - Headache: mild to moderate pain in the head region. - Dizziness: sensation of light‑headedness or unsteadiness. - Abdominal pain: cramping or tenderness in the stomach area. - Diarrhoea: loose, frequent stools.

Serious or Rare Side Effects: - Gastrointestinal bleeding: potentially life‑threatening hemorrhage. - Ulcer perforation: a hole in the stomach or intestinal lining. - Severe liver injury: jaundice, elevated enzymes, hepatic failure. - Stevens‑Johnson syndrome: serious skin and mucous membrane reaction. - Anaphylaxis: rapid, severe allergic response. - Acute renal failure: sudden loss of kidney function.

Before prescribing, clinicians should evaluate patient‑specific risk factors and monitor for adverse events. - Assess GI risk: review history of ulcers or gastrointestinal bleeding. - Monitor renal function: especially in patients with existing kidney disease. - Avoid in severe hepatic disease: liver impairment may alter drug metabolism. - Use with caution in elderly: increased susceptibility to side effects. - Avoid concomitant anticoagulants: heightened risk of bleeding. - Store at ambient temperature: keep in the original pack, protect from moisture.

Naproxen / Esomeprazole can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Corticosteroids: heightened ulcer risk when combined. - Selective serotonin reuptake inhibitors (SSRIs): may amplify bleeding tendency. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: may diminish renal perfusion and function. - ACE inhibitors or ARBs: possible decline in renal function. - Lithium: increased serum lithium concentrations. - Digoxin: altered absorption affecting drug levels. - Antacids containing aluminium or magnesium: may affect esomeprazole absorption.